For many people living with chronic pain following a nerve injury, the experience is one of profound frustration. The initial trauma—a deep cut, a crushed limb, or a pinched nerve—may have healed years ago, yet the pain persists, often radiating or intensifying without an obvious physical trigger. For decades, medicine has largely viewed these issues as localized failures of the nervous system to repair itself.
However, new preclinical research from McGill University suggests that the problem may be far more systemic. The study indicates that a localized nerve injury can trigger long-term, body-wide changes in the immune system, effectively “reprogramming” how the body responds to pain long after the original wound has closed. Crucially, the research reveals that these immune shifts are not universal; they differ significantly between males and females.
The findings, published in the journal Neurobiology of Pain, challenge the traditional approach to pain management by suggesting that chronic pain may be driven by circulating factors in the blood rather than just damaged wires in the periphery. By identifying these distinct biological pathways, researchers hope to move toward a more personalized approach to treatment that accounts for biological sex.
A Systemic Shift in Immune Activity
Nerve injuries are common clinical occurrences, resulting from various forms of trauma including stretching, compression, or direct lacerations. While the immune system is designed to enter the site of an injury to clear debris and facilitate repair, the McGill team found that this response does not always remain localized. Instead, the injury can spark a systemic inflammatory state.
In laboratory analyses of mice, researchers observed clear evidence of body-wide inflammation following a nerve injury. This suggests that the trauma of a nerve cut sends a signal that alters the behavior of immune cells throughout the entire organism. This systemic disruption is particularly concerning because long-lasting changes to immune function are often linked to more than just physical pain; they can contribute to systemic comorbidities, including anxiety and depression, which frequently accompany chronic pain syndromes.
The Gender Gap in Biological Pathways
One of the most striking aspects of the study was the “sexually dimorphic” nature of the immune response. The researchers found that male and female mice responded to the same type of nerve injury through entirely different biological mechanisms.
In male mice, the researchers detected a significant increase in inflammatory markers within the bloodstream. These markers remained elevated over time, providing a clear, measurable signature of systemic inflammation. In female mice, however, those same inflammatory markers did not rise. On the surface, this might suggest that females are less affected by the systemic fallout of nerve injury, but the researchers discovered a more complex reality.
To test whether something was happening in the blood regardless of the markers, the team performed a transfer experiment. They took blood from injured males and females and transferred it into healthy mice. In both cases—regardless of whether the blood came from a male or female—the healthy recipient mice developed an increased sensitivity to pain.
“That means whatever is causing pain in females is working through a completely different biological pathway that we don’t yet understand,” said co-author Jeffrey Mogil, E.P. Taylor Professor of Pain Studies at McGill and a Distinguished James McGill Professor.
This indicates that while the markers of inflammation differ by sex, the result—a systemic increase in pain sensitivity—is the same. The biological “messenger” carrying the pain signal in the blood of females is simply different from the one found in males.
Comparison of Immune Responses to Nerve Injury
| Feature | Response in Males (Mice) | Response in Females (Mice) |
|---|---|---|
| Blood Inflammatory Markers | Increased and remained elevated | No significant rise detected |
| Effect of Blood Transfer | Induced pain sensitivity in healthy mice | Induced pain sensitivity in healthy mice |
| Biological Pathway | Linked to known inflammatory markers | Operates via an unidentified pathway |
| Systemic Impact | Body-wide immune shift | Body-wide immune shift |
Implications for Personalized Medicine
The discovery that men and women may experience chronic pain through different biological channels has significant implications for clinical practice. For years, many pain medications have been developed using a “one size fits all” approach, often based on data that did not sufficiently account for sex-based biological differences.
If the drivers of chronic pain are different for males and females, then the treatments required to neutralize those drivers must also differ. “By understanding how men and women react differently to nerve injuries, we can work toward more personalized and effective treatments for chronic pain,” noted Sam Zhou, the study’s lead author and a PhD student at McGill.
Dr. Ji Zhang, the senior author and a professor at McGill’s Department of Neurology and Neurosurgery, emphasized that this shift in understanding is vital for patient care. “A localized nerve injury can affect the whole body,” Zhang said, noting that recognizing this full impact is essential for both physicians and patients to avoid overlooking the systemic nature of the condition.
The research was supported by the Canadian Institutes of Health Research and the Louise and Alan Edwards Foundation, underscoring the importance of public and philanthropic funding in exploring the nuances of pain biology.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The next phase of this research will likely focus on identifying the specific “hidden” molecules in the blood of females that trigger pain sensitivity. Pinpointing these pathways could lead to the development of targeted biologics or immunotherapies designed to block these signals before they lead to permanent chronic pain states.
Do you or a loved one deal with chronic pain following an injury? Share your experience in the comments or share this article to help spread awareness about the need for personalized pain medicine.
